Sol-Gel Technologies Ltd logo

SLGL

Sol-Gel Technologies Ltd

$5.8

Earnings Summary

Revenue
$0Mn
Net Profits
$-5.6Mn
Net Profit Margins
-186566.67%
PE Ratio
15.15

Highlights

Revenue:

Sol-Gel Technologies Ltd’s revenue fell -99.57% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, Sol-Gel Technologies Ltd has generated -99.99% fall in its revenue since last 3-months.

Net Profits:

Sol-Gel Technologies Ltd’s net profit fell -37.76% since last year same period to $-5.6Mn in the Q1 2022. On a quarterly growth basis, Sol-Gel Technologies Ltd has generated -139.89% fall in its net profits since last 3-months.

Net Profit Margins:

Sol-Gel Technologies Ltd’s net profit margin fell -32088.83% since last year same period to -186566.67% in the Q1 2022. On a quarterly growth basis, Sol-Gel Technologies Ltd has generated -276765.43% fall in its net profit margins since last 3-months.

PE Ratio:

Sol-Gel Technologies Ltd’s price-to-earnings ratio after this Q1 2022 earnings stands at 15.15.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Sol-Gel Technologies Ltd post its latest quarter earnings

EPS Estimate Current Quarter
-0.1
EPS Estimate Current Year
-0.1

Highlights

EPS Estimate Current Quarter:

Sol-Gel Technologies Ltd’s earning per share (EPS) estimates for the current quarter stand at -0.1 - a 65.52% jump from last quarter’s estimates.

EPS Estimate Current Year:

Sol-Gel Technologies Ltd’s earning per share (EPS) estimates for the current year stand at -0.1.

Key Ratios

Key ratios of the Sol-Gel Technologies Ltd post its Q1 2022 earnings

Earning Per Share (EPS)
-0.24
Return on Assets (ROA)
0.11
Return on Equity (ROE)
0.21
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Sol-Gel Technologies Ltd’s earning per share (EPS) fell -33.33% since last year same period to -0.24 in the Q1 2022. This indicates that the Sol-Gel Technologies Ltd has generated -33.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Sol-Gel Technologies Ltd’s return on assets (ROA) stands at 0.11.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Sol-Gel Technologies Ltd’s return on equity (ROE) stands at 0.21.

Dividend Per Share (DPS):

Sol-Gel Technologies Ltd declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-03-31
-0.29
-0.24
17.24%

Company Information

Sol-Gel is a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gel leverages its proprietary microencapsulation technology platform for the development of Twyneo, under investigation for the treatment of acne vulgaris, and Epsolay, under investigation for the treatment of inflammatory lesions of rosacea. The Company's pipeline also includes SGT-210 (erlotinib gel), under investigation for the treatment of palmoplantar keratoderma, and three pre-clinical assets - erlotinib, tapinarof and roflumilast - currently being tested for various pharmaceutical indications.

Organisation
Sol-Gel Technologies Ltd
Headquarters
7 Golda Meir, Ness Ziona, Israel
Employees
65
Industry
Health Technology
CEO
Alon Seri-Levy